Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...
India achieved a 21% TB incidence drop, surpassing global rates, with TB Mukt Bharat Abhiyan, advanced tech, Ni-kshay Poshan ...
The review also calls for embedding diagnostics within the One Health framework, which integrates human, animal, and ...
The global biologics market is expected to grow at a rate of 10-12% over the next five years. Key drivers behind this growth include the increasing prevalence of chronic diseases, ongoing advancements ...
In this interview, Dr. Kelemen discusses the advantages of lipid-based delivery systems and their potential to expand the ...
SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the third quarter ended September 30, 2025.
Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc.
11d
Bionano Genomics: Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress
Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the third quarter ended September 30, 2025. "Over the last year, we have taken ...
Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.
A slew of new studies and reports suggest that new molecular approaches may soon help reduce the global burden of tuberculosis.
Evo’s success wasn’t limited to proteins. When they tested a different toxin that had an RNA-based inhibitor, the system ...
Nucleic acids (DNA or RNA) are polymers of nucleotides – each nucleotide consists of a pentose sugar, a phosphate group and one of the nitrogenous bases (purines and pyrimidines). Nucleic acids ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback